HK1026145A1 - A composition for the treatment of irds and ards - Google Patents

A composition for the treatment of irds and ards

Info

Publication number
HK1026145A1
HK1026145A1 HK00105462A HK00105462A HK1026145A1 HK 1026145 A1 HK1026145 A1 HK 1026145A1 HK 00105462 A HK00105462 A HK 00105462A HK 00105462 A HK00105462 A HK 00105462A HK 1026145 A1 HK1026145 A1 HK 1026145A1
Authority
HK
Hong Kong
Prior art keywords
irds
ards
treatment
composition
difluoromethoxybenzamide
Prior art date
Application number
HK00105462A
Other languages
English (en)
Inventor
Dietrich Hafner
Paul-Georg Germann
Klaus Eistetter
Ulrich Kilian
Rolf Beume
Hermann Amschler
Uwe Kruger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19705924A external-priority patent/DE19705924A1/de
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of HK1026145A1 publication Critical patent/HK1026145A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK00105462A 1997-02-17 2000-08-31 A composition for the treatment of irds and ards HK1026145A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19705924A DE19705924A1 (de) 1997-02-17 1997-02-17 Neue Zusammensetzungen
EP97102639 1997-02-19
PCT/EP1998/000847 WO1998035683A1 (en) 1997-02-17 1998-02-14 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant

Publications (1)

Publication Number Publication Date
HK1026145A1 true HK1026145A1 (en) 2000-12-08

Family

ID=26033977

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00105462A HK1026145A1 (en) 1997-02-17 2000-08-31 A composition for the treatment of irds and ards

Country Status (26)

Country Link
US (2) US6436970B1 (xx)
EP (1) EP0977577B1 (xx)
JP (1) JP4763104B2 (xx)
KR (1) KR100640025B1 (xx)
CN (1) CN1123345C (xx)
AT (1) ATE336254T1 (xx)
AU (1) AU734122B2 (xx)
BR (1) BR9807399B1 (xx)
CA (1) CA2276429C (xx)
CZ (1) CZ293871B6 (xx)
DE (1) DE69835594T2 (xx)
DK (1) DK0977577T3 (xx)
EA (1) EA001758B1 (xx)
EE (1) EE04094B1 (xx)
ES (1) ES2271990T3 (xx)
HK (1) HK1026145A1 (xx)
HU (1) HU227520B1 (xx)
IL (1) IL130658A (xx)
NO (1) NO323594B1 (xx)
NZ (1) NZ336569A (xx)
PL (1) PL190775B1 (xx)
PT (1) PT977577E (xx)
SI (1) SI0977577T1 (xx)
TR (1) TR199901772T2 (xx)
UA (1) UA50808C2 (xx)
WO (1) WO1998035683A1 (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2271990T3 (es) * 1997-02-17 2007-04-16 Altana Pharma Ag Composiciones para el tratamiento de ards o irds que contienen 3- (ciclopropilmetoxi) -n- (3,5-dicloro-4-piridinil) -4- (difluorometoxi) benzamina y un tensioactivo pulmonar.
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
AU6196201A (en) * 2000-05-25 2001-12-03 Merck Frosst Canada Inc Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
DE60205899T2 (de) 2001-05-24 2006-06-29 Merck Frosst Canada & Co, Kirkland 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
US6998384B2 (en) * 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
BR0316475A (pt) * 2002-11-27 2005-10-11 Altana Pharma Ag Combinação sinergìstica que compreende roflumilast e (r,r)-formoterol
MXPA05005437A (es) * 2002-11-27 2005-08-03 Altana Pharma Ag Nueva combinacion sinergica que comprende roflumilast y formoterol.
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
ATE547104T1 (de) * 2003-06-16 2012-03-15 Nycomed Gmbh Zusammensetzung enthaltend einen lungensurfactant und sildenafil zur behandlung von lungenerkrankungen
AU2005268755B2 (en) * 2004-08-06 2011-04-07 Takeda Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
JP2010513276A (ja) * 2006-12-13 2010-04-30 ギリード・サイエンシズ・インコーポレーテッド 肺炎症および気管支収縮の治療のための抗炎症シグナル伝達モジュレーター（ＡＩＳＴＭ）およびβ−アゴニストの相互プロドラッグとしてのモノホスフェート
WO2009055788A1 (en) * 2007-10-26 2009-04-30 Aeris Therapeutics, Inc. Pneumoreductive therapy and compositions useful therein
ES2909752T3 (es) * 2013-08-01 2022-05-10 Swedish Stromabio Ab MSC en el tratamiento de enfermedades pulmonares inflamatorias
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法
RU2728821C1 (ru) * 2020-05-13 2020-07-31 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
NZ208107A (en) * 1983-05-11 1986-12-05 Byk Gulden Lomberg Chem Fab 6-aryl-3(2h)-pyridazinones and pharmaceutical compositions
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
EP0706513B1 (de) * 1993-07-02 2002-05-15 Byk Gulden Lomberg Chemische Fabrik GmbH Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
ES2271990T3 (es) * 1997-02-17 2007-04-16 Altana Pharma Ag Composiciones para el tratamiento de ards o irds que contienen 3- (ciclopropilmetoxi) -n- (3,5-dicloro-4-piridinil) -4- (difluorometoxi) benzamina y un tensioactivo pulmonar.
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
EP1206326A1 (en) * 1999-06-29 2002-05-22 L-Tech Corporation Chemical film cleaning and drying

Also Published As

Publication number Publication date
EP0977577A1 (en) 2000-02-09
US20020132835A1 (en) 2002-09-19
NO993875L (no) 1999-08-11
AU734122B2 (en) 2001-06-07
IL130658A (en) 2004-07-25
EA199900645A1 (ru) 2000-04-24
HUP0001043A2 (hu) 2000-09-28
CA2276429C (en) 2007-06-19
NO323594B1 (no) 2007-06-11
TR199901772T2 (xx) 1999-09-21
NZ336569A (en) 2001-04-27
JP2001512452A (ja) 2001-08-21
DE69835594D1 (de) 2006-09-28
PT977577E (pt) 2007-02-28
BR9807399A (pt) 2000-03-14
IL130658A0 (en) 2000-06-01
NO993875D0 (no) 1999-08-11
KR100640025B1 (ko) 2006-10-31
US6998410B2 (en) 2006-02-14
BR9807399B1 (pt) 2011-04-19
CA2276429A1 (en) 1998-08-20
ES2271990T3 (es) 2007-04-16
CZ293871B6 (cs) 2004-08-18
JP4763104B2 (ja) 2011-08-31
US6436970B1 (en) 2002-08-20
EP0977577B1 (en) 2006-08-16
CZ291499A3 (cs) 2000-02-16
SI0977577T1 (sl) 2007-02-28
DE69835594T2 (de) 2007-08-16
PL190775B1 (pl) 2006-01-31
KR20000071112A (ko) 2000-11-25
WO1998035683A1 (en) 1998-08-20
EE9900279A (et) 2000-02-15
HUP0001043A3 (en) 2002-12-28
HU227520B1 (hu) 2011-07-28
PL335134A1 (en) 2000-04-10
UA50808C2 (uk) 2002-11-15
ATE336254T1 (de) 2006-09-15
DK0977577T3 (da) 2006-12-18
AU6497398A (en) 1998-09-08
CN1248169A (zh) 2000-03-22
EE04094B1 (et) 2003-08-15
CN1123345C (zh) 2003-10-08
EA001758B1 (ru) 2001-08-27

Similar Documents

Publication Publication Date Title
HK1026145A1 (en) A composition for the treatment of irds and ards
DK1481682T3 (da) Præparat som indeholder oligosaccharider og probiotika
UA43378C2 (uk) Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих
ITTO940713A0 (it) Vaccino per la prevenzione della sindrome riproduttiva e respiratoria porcina.
GB2288732B (en) Pharmaceutical compositions
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
FI973603A (fi) Kuivapesujärjestelmä, jossa käytetään tiivistettyä hiilidioksidia ja pinta-aktiivista apuainetta
FI974346A (fi) Dehydroepiandrosteronijohdannaisia progressiivisen kudosnekroosin reperfuusiovaurion, bakteerien translokaation ja aikuisen hengitysvaikeusoireyhtymän estämiseksi
AU3662593A (en) Pulmonary surfactant protein fragments
FI96438C (fi) Ilmakehän hiilidioksidia vähentävä paperinvalmistusmenetelmä
EP0374089A3 (en) Use of somatostatin derivatives as lung protecting agents
ES2094837T3 (es) Metodo para inhibir la toxicidad pulmonar por oxigeno.
ZA913881B (en) Therapeutic agent
ES2188189T3 (es) Composiciones que comprenden derivados de acido fenil-amino-tiofeno-acetico para el tratamiento del sindrome de angustia respiratoria aguda o de adultos (ards) y del sindrome de angustia respiratoria de niños (irds).
SI1098645T1 (en) Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds)
FR2722869B1 (fr) 1procede de nettoyage des elements c2chauffage d'air, notamment d'un sec
SE9403591D0 (sv) Anordning för att befrämja barns identitetsutveckling
EP0860496A3 (de) Reinigungsmittel für Silberbad
ZA997090B (en) "A composition for the treatment of wood".

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20180213